Provider

The past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD).

A little bit of cash paired with a wearable activity tracker could be key in motivating people with ischemic heart disease to stay active.

Patients of doctors who participated in a Veteran Affairs-run telemedicine consultation program were 54 percent more likely to survive chronic liver disease than a matched cohort of patients of non-participating doctors, according to a new retrospective study from the University of Michigan.

The Centers for Medicare and Medicaid Services will reverse a longstanding unpopular position on reimbursement for smartphone-connected continuous glucose monitors, CMS announced yesterday.

When healthcare communications firm Spok first began investigating the prevalence of mobile strategies in 2012, only a third of survey respondents reported that their organization had a formalized strategy in place.

A clinical review, published in Evidence Based Mental Health Month, suggests numerous issues, including poor app design and privacy concerns, have contributed to a low engagement rate for mental health apps.

Switzerland-based MindMaze announced today that it has received FDA clearance for the MindMotion Go, a gamified neurorehabilitation therapy platform for medium and light severity impairments able to be deployed in the patient’s home.

Glooko announced the launch of the new version of its Glooko Web Application platform this morning.

A patent application filed by Apple, for a (possibly Bluetooth-connected) wearable blood pressure monitor, became public last week and was brought to light by The Verge.

The UK has an opportunity to 'lead the world in the use of data and technology to prevent illness', Prime Minister Theresa May said in a speech today marking a £20bn funding boost for the NHS.